Cure8 research brief
Automated, sequence-robust MRI measures could help standardize detection and localization of perianal anoperineal lesions in Crohn’s disease, which is relevant for diagnosis and management of perianal complications.
Clinicians and radiologists evaluating perianal Crohn’s disease; researchers in imaging/AI for IBD; patients with perianal disease and their caregivers.
The authors developed left-right asymmetry features from axial pelvic MRI images and tested them on a cohort of 44 Crohn’s patients with 134 MRI sequences. On a proof-of-concept subset (excluding symmetrical lesions) the classifier showed strong performance (AUC > 0.85) and lesion-localization median error around 1.0–1.2 cm.
Performance dropped on broader validation and test sets (AUCs ~0.65–0.67), and the method struggled with symmetrical (horseshoe) lesions. The work is presented as a proof-of-concept emphasizing interpretability and sequence-robustness rather than a ready clinical tool.
Larger, more diverse annotated datasets and further validation would be needed before clinical deployment.
Small single-study proof-of-concept with reduced generalization on validation/test sets and noted difficulty with symmetrical lesions; further larger validation required before clinical use.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
People with Crohn's disease who have an ileostomy need reliable, noninvasive tools to monitor for postoperative small-bowel inflammation. This study suggests fecal calprotectin measured from ileostomy output may help...
Risk stratification helps identify people with Crohn's who are more likely to develop strictures, fistulas, or need surgery so clinicians can monitor and treat them more aggressively early on. Objective tests like fecal...
New PET tracers like FAPI could better detect fibrosis and stromal activity than standard FDG-PET, which may improve imaging of fibrostenotic Crohn's disease. For people with IBD, improved imaging might eventually help...
